Oncopeptides AB (publ) (STO:ONCO)

Oncopeptides AB Revenue

Oncopeptides AB had revenue of 19.18M SEK in the quarter ending June 30, 2025, with 135.23% growth. This brings the company's revenue in the last twelve months to 50.87M, up 138.06% year-over-year. In the year 2024, Oncopeptides AB had annual revenue of 31.65M, down -10.14%.

• Revenue (ttm): 50.87M
• Revenue Growth: +138.06%
• P/S Ratio: 32.37
• Revenue / Employee: 678.27K
• Employees: 80
• Market Cap: 1.65B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	31.65M	-3.57M	-10.14%
Dec 31, 2023	35.22M	26.87M	321.54%
Dec 31, 2022	8.36M	-109.94M	-92.94%
Dec 31, 2021	118.30M	-	-
Dec 31, 2020	-	-	-